Medicare Enrollment Periods and Penalties: What Insurers Need to Know
Understand Medicare enrollment periods and penalties with insights on timely Medicare Part B registration, COBRA implications, and penalty costs for insurance professionals.
Understand Medicare enrollment periods and penalties with insights on timely Medicare Part B registration, COBRA implications, and penalty costs for insurance professionals.
Blue Shield of California reports the largest healthcare data breach of 2025 due to a misconfigured Google Analytics setup, exposing sensitive patient information and highlighting data privacy challenges in health insurance.
Rodney L. Yentzer sentenced to 42 months for defrauding Medicare and Medicaid through unnecessary urine drug tests, resulting in multi-million dollar restitution. Case underscores insurance fraud risks in healthcare diagnostic billing.
Understand Medicare enrollment requirements for self-employed individuals with individual health plans to avoid Part B penalties and coverage gaps. Learn key distinctions from group employer plans and enrollment deadlines.
Massachusetts jury delivers mixed verdict in SEC case against Jeffrey Cutter for annuity sales violations under the Investment Advisers Act. Highlights fiduciary duty and disclosure compliance issues.
iA Financial Group leverages FICO Platform to automate 80% of life insurance underwriting, enhancing efficiency and risk management while ensuring regulatory compliance in Canada’s insurance market.
Blue Shield of California notifies 4.7 million members after patient data exposure through Google Analytics, highlighting healthcare data privacy challenges in 2025.
Campbell County School Board in Tennessee resolved a dispute over the signing of a health insurance memorandum of understanding, clarifying fiscal officer roles to maintain employee benefits compliance.
Federal workforce cuts have reduced caseworker support for ACA enrollees, complicating resolution of health coverage issues as new rules increase complexity.
U.S. cancer death rates declined steadily from 2001 to 2022, including during the pandemic, driven by advances in detection and treatment. Regulatory fraud enforcement and new FDA approvals impact healthcare and insurance sectors.